We are working to research, develop, and produce next-generation transdermal cosmetics using our industry-academia patented ATD²S® technology. This is a technology that applies and evolves the “deliver what is needed, where it is needed, and how much is needed” drug delivery system to allow for the direct and stable delivery of hydrophilic and macromolecular ingredients deep into the skin, and we are developing revolutionary cosmetics products that improve the utilization of beneficial beauty ingredients. Area of Interest
Site-visit
Not allowed
SDGs we are working on
3.Good health and well-being5.Gender equality8.Decent work and economic growth9.Industry, innovation, infrastructure12.Responsible consumption, production
Registered Keyword
We signed a technology advisory agreement with Kyushu University's Advanced Transdermal Drug Delivery System Center and became a licensee of Kyushu University's patented technology in 2017. We are developing revolutionary cosmetics products that improve the utilization of beneficial beauty ingredients and enable the direct and stable delivery of hydrophilic and macromolecular ingredients deep into the skin with ATD²S®, our next-generation transdermal technology that applies and evolves the “deliver what is needed, where it is needed, and how much is needed” drug delivery system.
ATD2S® technology has major advantages in transdermal absorption and stability.
Product development with major retailers, manufacturers, and medical institutions
Received the Ministry of Education, Culture, Sports, Science and Technology Nanotechnology Platform “Outstanding Utilization Results”